COMMUNIQUÉS West-GlobeNewswire

Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

26/09/2019 - 14:32

BLUE BELL, Pa., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]

Mustang Bio to Participate in October 2019 Investor Conferences

26/09/2019 - 14:30

NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]

Spero Therapeutics Announces Presentations at IDWeek 2019

26/09/2019 - 14:30

CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]

Fortress Biotech to Present at October 2019 Investor Conferences

26/09/2019 - 14:30

NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]

Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

26/09/2019 - 14:30

NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

26/09/2019 - 14:27

EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will provide a corporate update at the 2019 Cantor Fitzgerald Global [...]

Ascendis Pharma A/S Announces Upcoming Investor Presentation in October

26/09/2019 - 14:25

COPENHAGEN, Denmark, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]

CorMedix Inc. Announces Exercises of Outstanding Warrants

26/09/2019 - 14:15

BERKELEY HEIGHTS, N.J., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]

Imagin Medical Announces Meeting Regarding i/Blue’s Regulatory Pathway

26/09/2019 - 14:13

VANCOUVER, British Columbia and BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met [...]

Three Recent Preclinical Publications Highlight NMDA Receptor Activation Facilitated by Aptinyx’s NYX-2925

26/09/2019 - 14:07

Data published across three peer-reviewed journals elucidate novel mechanism leading to enhanced synaptic plasticity EVANSTON, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage [...]

Cocrystal Pharma to Present at the 2019 Cantor Global Healthcare Conference

26/09/2019 - 14:05

- Presentation on Friday, October 4 th at 1:45 PM ET - BOTHELL, WA, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company [...]

Gritstone Oncology to Present at Cantor Global Healthcare Conference

26/09/2019 - 14:00

EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]

Catalyst Biosciences to Present at the Cantor Global Healthcare Conference

26/09/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will [...]

MDxHealth Launches Capital Increase and Secures Debt Financing from Kreos Capital

26/09/2019 - 14:00

Press release Regulated information – Inside information 26 September 2019, 2:00 p.m. CEST IRVINE, CA, and HERSTAL, BELGIUM – 26 September 2019 – MDxHealth SA (Euronext Brussels: MDXH) (the " Company " or " MDxHealth [...]

MDxHealth Lance une Augmentation de Capital et Obtient un Financement par Emprunt auprès de Kreos Capital

26/09/2019 - 14:00

Communiqué de presse Information réglementée - Information privilégiée 26 septembre 2019, 14H00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) – le 26 septembre 2019 – MDxHealth SA (Euronext Brussels: MDXH) (la " Société " ou " [...]

Apellis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference

26/09/2019 - 14:00

CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference

26/09/2019 - 14:00

LAKE FOREST, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare [...]

LogicBio Therapeutics to Present at October Conferences

26/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today [...]

Immutep Announces Expansion of Part A of TACTI-002 Phase II Clinical Trial due to Positive Interim Data

26/09/2019 - 14:00

Requisite clinical responses achieved in cohort 1 of Part A (1 st line NSCLC) of TACTI-002 Phase II clinical trial to allow for recruitment of cohort 2 Recruitment of cohort 2 of Part A of TACTI-002, additional 19 [...]